Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
Years Aggregate
CFO
CA$--
EBITDA
CA$--
Net Profit
CA$--
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Field Trip Health (REUN)
| 24.4 | 0.9 | 45.5 | -73.5 | -- | -- | -- |
|
BSE Sensex*
| -10.1 | -3.6 | 2.5 | -5.7 | 4.9 | 5.5 | 10.1 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Field Trip Health (REUN)
Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic... product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada. Read more
-
Co-Founder & Non-Independent Director
Mr. Hannan Fleiman
-
Co-Founder & Non-Independent Director
Mr. Hannan Fleiman
-
Headquarters
Toronto, ON
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Field Trip Health (REUN)
What is the current share price of Field Trip Health Ltd (REUN) Today?
The share price of Field Trip Health Ltd (REUN) is $1.12 (NASDAQ) as of 04-Aug-2023 09:30 EDT. Field Trip Health Ltd (REUN) has given a return of -73.47% in the last 1 years.
What is the current PB & PE ratio of Field Trip Health Ltd (REUN)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2023 |
-0.13 |
0.39 |
2022 |
-0.29 |
0.24 |
2021 |
-- |
-- |
2020 |
-- |
-- |
2023 |
-0.13 |
0.39 |
What is the 52 Week High and Low of Field Trip Health Ltd (REUN)?
The 52-week high and low of Field Trip Health Ltd (REUN) are Rs -- and Rs -- as of 07-Sep-2026.
What is the market cap of Field Trip Health Ltd (REUN)?
Field Trip Health Ltd (REUN) has a market capitalisation of $ 13 Mln as on 04-Aug-2023. As per SEBI classification, it is a Small Cap company.
Should I invest in Field Trip Health Ltd (REUN)?
Before investing in Field Trip Health Ltd (REUN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.